About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluation Of Serum MIF Level in SLE Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05253638

Evaluation Of Serum MIF Level in SLE Patients

Systemic lupus erythematosis (SLE) is a chronic autoimmune disease characterized by production of autoantibodies and the deposition of immune complexes, affecting a wide range of organs. The clinical ...

Lead sponsor: Assiut University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Assiut University

Age

18 - 40 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adult SLE patients \>18 years
•fulfilled the 2012 systemic lupus international collaborating clinics (SLICC) criteria

Exclusion Criteria

•Patients with overlap syndrome, pregnancy, active infection, diseases other than SLE that might produce abnormal proteinuria.
•Individuals with other autoimmune diseases (rheumatoid arthritis, dermatomyositis, scleroderma, mixed connective tissue disease).

Related studies

RECRUITINGPhase 2

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

NCT07409181 · Systemic Lupus Erythematosus

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

NCT07043153 · Systemic Lupus Erythematosus Disease

RECRUITINGPhase 1

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

NCT05869955 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, and more

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more

RECRUITINGEARLY Phase 1

MTS109 in Patients With Refractory Autoimmune Diseases

NCT07526350 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment60

Start dateFeb 2022

Last updatedFeb 24, 2022

Condition

Systemic Lupus Erythematosus

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions